Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosuke Yamaguchi

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Nature Communications|May 27, 2022
Histone functions as a cell-surface receptor for AGEsMasanori Itakura, Kosuke Yamaguchi, Roma Kitazawa, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 1, 2013
The 6-minute pegboard and ring test is correlated with upper extremity activity of daily living in chronic obstructive pulmonary diseaseKenichi Takeda, Yuji Kawasaki, Kazumasa Yoshida, et al.
Yonago Acta Medica|February 20, 2026
Longitudinal Dynamics of Soluble NKG2D Ligands in Mild and Moderate Coronavirus Disease-2019Kyosuke Nagamizu, Yukari Nishikawa, Miyako Takata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell linesJun Kurai, Hiroki Chikumi, Kiyoshi Hashimoto, et al.
Bioorganic & Medicinal Chemistry|November 21, 2021
Structure-based screening combined with computational and biochemical analyses identified the inhibitor targeting the binding of DNA Ligase 1 to UHRF1Satomi Kori, Yuki Shibahashi, Toru Ekimoto, et al.
Internal Medicine (Tokyo, Japan)|February 9, 2025
Pseudo-hyperprogression of Malignant Pleural Mesothelioma Treated with Nivolumab: A Case ReportMasaaki Yanai, Tomohiro Sakamoto, Takafumi Nonaka, et al.
The Journal of Medical Investigation : JMI|March 30, 2018
Evaluation of antigen-positive toxin-negative enzyme immunoassay results for the diagnosis of toxigenic Clostridium difficile infectionYukinobu Akamatsu, Shota Morishita, Hiroki Chikumi, et al.
Internal Medicine (Tokyo, Japan)|February 2, 2025
Successful Switch to Afatinib and Osimertinib Rechallenge with Corticosteroids after Osimertinib-induced Interstitial Lung Disease: A Case Report and Literature ReviewMasaaki Yanai, Tomohiro Sakamoto, Naoki Uetani, et al.
International Journal of Oncology|January 9, 2014
Synergistic cell growth inhibition by the combination of amrubicin and Akt-suppressing agents in K-ras mutation-harboring lung adenocarcinoma cells: implication of EGFR tyrosine kinase inhibitorsShizuka Ito, Tadashi Igishi, Miyako Takata, et al.
International Journal of Oncology|August 28, 2012
Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesotheliomaJun Kurai, Hiroki Chikumi, Kiyoshi Hashimoto, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Nature Communications|May 27, 2022
Histone functions as a cell-surface receptor for AGEsMasanori Itakura, Kosuke Yamaguchi, Roma Kitazawa, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 1, 2013
The 6-minute pegboard and ring test is correlated with upper extremity activity of daily living in chronic obstructive pulmonary diseaseKenichi Takeda, Yuji Kawasaki, Kazumasa Yoshida, et al.
Yonago Acta Medica|February 20, 2026
Longitudinal Dynamics of Soluble NKG2D Ligands in Mild and Moderate Coronavirus Disease-2019Kyosuke Nagamizu, Yukari Nishikawa, Miyako Takata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell linesJun Kurai, Hiroki Chikumi, Kiyoshi Hashimoto, et al.
Bioorganic & Medicinal Chemistry|November 21, 2021
Structure-based screening combined with computational and biochemical analyses identified the inhibitor targeting the binding of DNA Ligase 1 to UHRF1Satomi Kori, Yuki Shibahashi, Toru Ekimoto, et al.
Internal Medicine (Tokyo, Japan)|February 9, 2025
Pseudo-hyperprogression of Malignant Pleural Mesothelioma Treated with Nivolumab: A Case ReportMasaaki Yanai, Tomohiro Sakamoto, Takafumi Nonaka, et al.
The Journal of Medical Investigation : JMI|March 30, 2018
Evaluation of antigen-positive toxin-negative enzyme immunoassay results for the diagnosis of toxigenic Clostridium difficile infectionYukinobu Akamatsu, Shota Morishita, Hiroki Chikumi, et al.
Internal Medicine (Tokyo, Japan)|February 2, 2025
Successful Switch to Afatinib and Osimertinib Rechallenge with Corticosteroids after Osimertinib-induced Interstitial Lung Disease: A Case Report and Literature ReviewMasaaki Yanai, Tomohiro Sakamoto, Naoki Uetani, et al.
International Journal of Oncology|January 9, 2014
Synergistic cell growth inhibition by the combination of amrubicin and Akt-suppressing agents in K-ras mutation-harboring lung adenocarcinoma cells: implication of EGFR tyrosine kinase inhibitorsShizuka Ito, Tadashi Igishi, Miyako Takata, et al.
International Journal of Oncology|August 28, 2012
Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesotheliomaJun Kurai, Hiroki Chikumi, Kiyoshi Hashimoto, et al.
Pageof 6